Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
Sponsor: Neurocrine Biosciences
Check if you qualify for this major depressive disorder clinical trial in Atlanta, GA
If you're searching for major depressive disorder treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.